Jane Fernandez
Psychiatry · Stockton, CANPI 1194799395
Payments from drug & device makers
Across 216 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$591
- AbbVie$531
- Sunovion Pharmaceuticals Inc.$517
- Takeda Pharmaceuticals U.S.A., Inc.$407
- Otsuka America Pharmaceutical, Inc.$385
- Alkermes, Inc.$172
- plus $988 from 15 others
What the payments were for
- Food & beverage$3,590100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 36 | $591 |
| AbbVie(2 entities) | 41 | $531 |
| Sunovion Pharmaceuticals Inc. | 32 | $517 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $407 |
| Otsuka America Pharmaceutical, Inc. | 18 | $385 |
| Alkermes, Inc. | 8 | $172 |
| Vanda Pharmaceuticals Inc. | 6 | $169 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $155 |
| Neurocrine Biosciences, Inc. | 5 | $122 |
| Johnson & Johnson | 5 | $96 |
| Tris Pharma Inc | 4 | $93 |
| Idorsia Pharmaceuticals US Inc | 5 | $82 |
| Avanir Pharmaceuticals, Inc. | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Ironshore Pharmaceuticals Inc. | 2 | $34 |
| Corium, LLC | 1 | $31 |
| Sage Therapeutics, LLC | 1 | $27 |
| Almatica Pharma LLC | 1 | $23 |
| Alfasigma USA, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $16 |
How this compares
$3,590 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 26 | $62,024 |
| Invega SustennaPaliperidone Palmitate | 14 | $47,069 |
| Lurasidone Hcl | 14 | $25,905 |
| VraylarCariprazine Hcl | 15 | $20,592 |
| Aripiprazole | 111 | $7,938 |
| TrintellixVortioxetine Hydrobromide | 14 | $7,374 |
| Quetiapine Fumarate | 128 | $2,820 |
| Asenapine Maleate | 12 | $2,674 |
| Duloxetine Hcl | 121 | $2,144 |
| Bupropion XlBupropion Hcl | 72 | $1,622 |
| Trazodone Hcl | 124 | $1,303 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 20 | $1,264 |
| Clozapine | 27 | $911 |
| Gabapentin | 58 | $888 |
| Escitalopram Oxalate | 53 | $728 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $385 | $62,02426 claims |
| Johnson & JohnsonInvega Sustenna | $96 | $47,06914 claims |
| AbbVieVraylar | $531 | $20,59215 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $407 | $7,37414 claims |
| Almatica Pharma LLCSertraline Hcl | $23 | $41877 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Stockton
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.